SCHEMBL24944693

SCHEMBL24944693

COc1cc(C(=O)OC2(c3ccccc3)CCNCC2)cc(OC)c1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.48
TSHR P16473 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ALDH1A1 P00352 1/20 0.45
CYP1A2 P05177 1/20 0.45
TNFRSF1A P19438 1/20 0.45
PKM P14618 1/20 0.43
SLC29A1 Q99808 2/20 0.41
MAPT P10636 1/20 0.41
THRB P10828 1/20 0.41
MAPK1 P28482 1/20 0.41
TUBB4A P04350 2/20 0.41
TUBB P07437 2/20 0.41
TUBA3C P0DPH7 2/20 0.41
TUBA1B P68363 2/20 0.41
TUBA4A P68366 2/20 0.41
TUBB4B P68371 2/20 0.41
TUBB3 Q13509 2/20 0.41
TUBB2A Q13885 2/20 0.41
TUBB8 Q3ZCM7 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26478947 0.89 SIGMAR1 (0.39) L3MBTL1TSHRSMN1; SMN2ALDH1A1CYP1A2
SCHEMBL24944094 0.88 NPC1 (0.47) L3MBTL1TSHRALDH1A1CYP1A2TNFRSF1A
SCHEMBL24944679 0.86 OPRM1 (0.41) L3MBTL1SMN1; SMN2TNFRSF1AMEN1KMT2A
SCHEMBL26413647 0.86 HTT (0.48) SMN1; SMN2ALDH1A1CYP1A2MAPTMEN1
SCHEMBL24944850 0.85 TACR1 (0.47) TSHRSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL24944087 0.85 SIGMAR1 (0.38) L3MBTL1MAPTMEN1KMT2AOPRM1
SCHEMBL24944282 0.84 SIGMAR1 (0.41) L3MBTL1ALDH1A1MAPTMEN1KMT2A
SCHEMBL24944657 0.83 OPRM1 (0.41) SMN1; SMN2CYP1A2TNFRSF1AMEN1KMT2A
SCHEMBL26478761 0.82 CYP1A2 (0.51) L3MBTL1SMN1; SMN2ALDH1A1CYP1A2PKM
SCHEMBL24944707 0.82 SMN1; SMN2 (0.44) L3MBTL1SMN1; SMN2ALDH1A1CYP1A2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11644753-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-05-09 US disclosed
US-11644753-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-05-09 US disclosed
US-20230131303-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-04-27 US disclosed
US-20230131303-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-04-27 US disclosed
US-20230021453-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11644753-B2 Resist composition and patterning process HNRNPU, NSUN2, HNRNPR L3MBTL1 2012/4885TSHR 3385/4885SMN1; SMN2 1285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.